Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Orgenesis Inc (NASDAQ: ORGS) was $0.67 for the day, down -2.60% from the previous closing price of $0.69. In other words, the price has decreased by -$2.60 from its previous closing price. On the day, 84483.0 shares were traded. ORGS stock price reached its highest trading level at $0.69 during the session, while it also had its lowest trading level at $0.653.
Ratios:
Our analysis of ORGS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.07 and its Current Ratio is at 0.07.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 01 ’24 when Safier Jacob bought 10,100 shares for $0.33 per share. The transaction valued at 3,332 led to the insider holds 3,110,100 shares of the business.
Safier Jacob bought 100,000 shares of ORGS for $68,950 on Sep 21 ’23. The 10% Owner now owns 2,839,860 shares after completing the transaction at $0.69 per share. On Nov 02 ’23, another insider, Safier Jacob, who serves as the 10% Owner of the company, bought 20,000 shares for $0.84 each. As a result, the insider paid 16,888 and bolstered with 2,920,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGS now has a Market Capitalization of 31435660 and an Enterprise Value of 44085664. For the stock, the TTM Price-to-Sale (P/S) ratio is 47.63. Its current Enterprise Value per Revenue stands at 66.595 whereas that against EBITDA is -2.313.
Stock Price History:
Over the past 52 weeks, ORGS has reached a high of $1.08, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is -4.45%, while the 200-Day Moving Average is calculated to be 18.82%.
Shares Statistics:
ORGS traded an average of 198.04K shares per day over the past three months and 124510 shares per day over the past ten days. A total of 46.93M shares are outstanding, with a floating share count of 41.59M. Insiders hold about 11.36% of the company’s shares, while institutions hold 4.66% stake in the company. Shares short for ORGS as of 1723680000 were 445474 with a Short Ratio of 2.25, compared to 1721001600 on 242552. Therefore, it implies a Short% of Shares Outstanding of 445474 and a Short% of Float of 1.08.
